Why Choose The Neurological Institute

Overview

About the Neurological Institute

The multidisciplinary Cleveland Clinic Neurological Institute includes more than 300 medical, surgical and research specialists dedicated to the treatment of adult and pediatric patients with neurological and psychiatric disorders. The institute offers a disease-specific, patient-focused approach to care. Our unique, fully integrated model strengthens our current standard of care, allows us to measure quality and outcomes on a continual basis, and enhances our ability to conduct research. Our neurology, neurosurgery, and pediatric neurology and neurosurgery programs are nationally ranked for their expertise and care.

• View our departments and centers.

We provide care across the spectrum of neurological disorders, including primary and metastatic tumors of the brain, spine, and nerves; pediatric and adult epilepsy; headache, facial pain syndromes and associated disorders; movement disorders such as Parkinson’s disease, essential tremor and dystonia; cerebral palsy and spasticity; hydrocephalus; metabolic and mitochondrial disease; fetal and neonatal neurological problems; multiple sclerosis; stroke; cerebral aneurysms; brain and spinal vascular malformations; carotid stenosis; intracranial atherosclerosis; nerve and muscle diseases, including amyotrophic lateral sclerosis, peripheral neuropathy, myasthenia gravis and myopathies; sleep disorders; and mental/behavioral health disorders and chemical dependencies.

Neurological Institute Chairmen:

• Andre Machado, MD, PhD Chairman, Neurological Institute.
• William Bingaman, MD Vice Chairman, Clinical Practice, Neurological Institute.
• Jay Alberts, PhD Vice Chairman, Health Technology Enablement, Neurological Institute.
• M. Shazam Hussain, MD Vice Chairman, Operations & Quality Improvement Office, Neurological Institute.
• Robert Fox, MD Vice Chairman, Research, Neurological Institute.
• Imad Najm, MD Vice Chairman, Strategy & Development, Neurological Institute.
• Leopoldo Pozuelo, MD Chairman, Department of Behavioral Health, Neurological Institute.
• Michael Steinmetz, MD Chairman, Department of Neurological Surgery, Neurological Institute.
• Kerry Levin, MD Chairman, Department of Neurology, Neurological Institute.
• Francois Bethoux, MD Chairman, Department of Physical Medicine & Rehabilitation, Neurological Institute.
• Bruce Trapp, PhD Chairman, Department of Neurosciences, Lerner Research Institute.
• Ajit Krishnaney, PhD Officer, Continuous Improvement, Neurological Institute.
• Xin Xin Yu, MD Officer, Patient Experience, Neurological Institute.
• Dolora Wisco, MD Officer, Quality Improvement, Neurological Institute.

The Knowledge Program

Cleveland Clinic’s Neurological Institute treats over 140,000 patients every year, making it one of the busiest centers for neurological diagnosis and treatment in the country. The Institute has developed the Knowledge Program© to leverage this patient volume to systematically analyze patient care and improve outcomes. This initiative allows us to consistently measure each patient’s illness severity over time and assess the efficacy of our treatment protocols, while accelerating the collection of electronic data.

The Knowledge Program is a system which allows patients to record a self assessment directly into their EMR (Electronic Medical Record). This is information that is traditionally gathered by physicians or nurses; however this method makes the information readily available in the future.

• This assessment takes approximately 5-10 minutes and is conducted at the beginning of each appointment.
• The self assessment begins with 10 general questions based on the PROMIS Global Health Questionnaire.
• Following the general questions patients will be asked further questions based on their specific condition (i.e. epilepsy, sleep disorders, etc).
• After the patient enters the data the information is automatically stored in the Knowledge Program database and transferred to the patients EMR.
• This data can be reviewed immediately by those with access rights.
• The information collected provides updates in patient status and insight into clinically relevant issues that may be otherwise overlooked.

This initiative is also a useful tool when demonstrating treatment efficacy and outcomes to payers, government agencies, and the public. This is especially important as government and private insurers move toward value-based reimbursement.